Skip to Content

2021

Oct 14

Written By Guest User

Sep - NIH Phase 1 grant to develop Alzheimer’s (tauopathies) therapy

Jul - Closes Seed round led by Two Bear Capital

Guest User

2020

Novoroo Bioscience provides the novoroo.com website as a service to the public and website owners. Novoroo Bioscience is not responsible for, and expressly disclaims all liability for, damages of any kind arising out of use, reference to, or reliance on any information contained within the website. While the information contained within the website is periodically updated, no guarantee is given that the information provided in this website is correct, complete, and up-to-date. Although the Novoroo Bioscience website may include links providing direct access to other Internet resources, including websites, Novoroo Bioscience is not responsible for the accuracy or content of information contained in these websites. Links from Novoroo Bioscience to third-party websites do not constitute an endorsement by Novoroo Bioscience of the parties or their products and services.